PTC Therapeutics Statistics
Total Valuation
PTCT has a market cap or net worth of $5.29 billion. The enterprise value is $6.11 billion.
| Market Cap | 5.29B |
| Enterprise Value | 6.11B |
Important Dates
The last earnings date was Thursday, October 29, 2026, after market close.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTCT has 83.54 million shares outstanding. The number of shares has decreased by -1.99% in one year.
| Current Share Class | 83.54M |
| Shares Outstanding | 83.54M |
| Shares Change (YoY) | -1.99% |
| Shares Change (QoQ) | -9.28% |
| Owned by Insiders (%) | 2.38% |
| Owned by Institutions (%) | 114.75% |
| Float | 73.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 29.42 |
| PS Ratio | 4.58 |
| Forward PS | 3.94 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2,560.89 |
| P/OCF Ratio | 504.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.73, with an EV/FCF ratio of 2,954.56.
| EV / Earnings | n/a |
| EV / Sales | 5.28 |
| EV / EBITDA | 19.73 |
| EV / EBIT | 24.57 |
| EV / FCF | 2,954.56 |
Financial Position
The company has a current ratio of 3.27
| Current Ratio | 3.27 |
| Quick Ratio | 3.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | 8.89 |
| Debt / FCF | 1,423.14 |
| Interest Coverage | 1.25 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 5.31% |
| Return on Invested Capital (ROIC) | 10.12% |
| Return on Capital Employed (ROCE) | 10.22% |
| Weighted Average Cost of Capital (WACC) | 6.45% |
| Revenue Per Employee | $1.17M |
| Profits Per Employee | -$106,933 |
| Employee Count | 991 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 6.39 |
Taxes
In the past 12 months, PTCT has paid $20.88 million in taxes.
| Income Tax | 20.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.17% in the last 52 weeks. The beta is 0.51, so PTCT's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -14.17% |
| 50-Day Moving Average | 64.28 |
| 200-Day Moving Average | 70.23 |
| Relative Strength Index (RSI) | 48.26 |
| Average Volume (20 Days) | 1,090,528 |
Short Selling Information
The latest short interest is 8.30 million, so 9.94% of the outstanding shares have been sold short.
| Short Interest | 8.30M |
| Short Previous Month | 9.17M |
| Short % of Shares Out | 9.94% |
| Short % of Float | 11.25% |
| Short Ratio (days to cover) | 6.38 |
Income Statement
In the last 12 months, PTCT had revenue of $1.16 billion and -$105.97 million in losses. Loss per share was -$1.28.
| Revenue | 1.16B |
| Gross Profit | 637.69M |
| Operating Income | 248.55M |
| Pretax Income | -85.09M |
| Net Income | -105.97M |
| EBITDA | 309.56M |
| EBIT | 248.55M |
| Loss Per Share | -$1.28 |
Balance Sheet
The company has $2.13 billion in cash and $2.94 billion in debt, with a net cash position of -$813.72 million or -$9.74 per share.
| Cash & Cash Equivalents | 2.13B |
| Total Debt | 2.94B |
| Net Cash | -813.72M |
| Net Cash Per Share | -$9.74 |
| Equity (Book Value) | -191.21M |
| Book Value Per Share | -2.29 |
| Working Capital | 1.76B |
Cash Flow
In the last 12 months, operating cash flow was $10.49 million and capital expenditures -$8.42 million, giving a free cash flow of $2.07 million.
| Operating Cash Flow | 10.49M |
| Capital Expenditures | -8.42M |
| Depreciation & Amortization | 61.01M |
| Net Borrowing | 131.47M |
| Free Cash Flow | 2.07M |
| FCF Per Share | $0.02 |
Margins
Gross margin is 55.18%, with operating and profit margins of 21.51% and -9.17%.
| Gross Margin | 55.18% |
| Operating Margin | 21.51% |
| Pretax Margin | -7.36% |
| Profit Margin | -9.17% |
| EBITDA Margin | 26.79% |
| EBIT Margin | 21.51% |
| FCF Margin | 0.18% |
Dividends & Yields
PTCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.99% |
| Shareholder Yield | 1.99% |
| Earnings Yield | -2.02% |
| FCF Yield | 0.04% |
Analyst Forecast
The average price target for PTCT is $100.47, which is 58.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $100.47 |
| Price Target Difference | 58.57% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | -1.96% |
| EPS Growth Forecast (3Y) | -19.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTCT has an Altman Z-Score of 1.04 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.04 |
| Piotroski F-Score | 4 |